Weiss Multi-Strategy Advisors increases to 8.8% its passive stake in Entrust

By E. Janene Geiss

Philadelphia, Oct. 20 - Weiss Multi-Strategy Advisors LLC increased its investment by 3.72% in Entrust Inc., as of Oct. 9, according to an SC 13G/A filing with the Securities and Exchange Commission.

The company reported an 8.8% passive stake, representing 5,422,025 shares.

It previously disclosed owning 3,100,000 shares - or a 5.08% passive stake - in Entrust on Feb. 26, 2008, according to an earlier SC 13G filing.

Fairfield, N.J.-based Unigene is a biopharmaceutical company focusing on the oral and nasal delivery of peptide-based drugs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.